Home > Search Results: Reumatologia Clinica
  Search Tips
Advanced Search
Search collections:
Sort by: Display results: Output format:
UAB Digital Repository of Documents 2 records found  Search took 0.01 seconds. 
1.
9 p, 964.3 KB Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis Documento de expertos sobre el uso de terapia combinada de metotrexato con terapias biológicas o terapias dirigidas a pacientes con artritis reumatoide / Tornero-Molina, J. (Hospital de Guadalajara) ; Alperi-López, M. (Hospital Universitario Central de Asturias) ; Castellvi, Ivan (Institut d'Investigació Biomèdica Sant Pau) ; De Agustin, Juan Jose (Hospital Universitari Vall d'Hebron) ; Escudero, A. (Hospital Universitario Reina Sofía) ; García-Vicuña, R. (Hospital Universitario La Princesa) ; González-Gay, M.Á. (Hospital Universitario Marqués de Valdecilla (Santander, Cantabria)) ; Hidalgo, C. (Complejo Asistencial Universitario de Salamanca) ; Rubio, E. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Sanmartí, Raimon (Hospital Clínic i Provincial de Barcelona) ; Casamira, N. (Laboratorios Gebro Pharma) ; Calvo Alén, Jaime (Hospital Universitario Araba) ; Universitat Autònoma de Barcelona
We aimed to develop recommendations for the management of methotrexate (MTX) when considering the combination with biological (b) or targeted synthetic (ts) disease modifying drugs (DMARDs) in rheumatoid arthritis (RA). [...]
2022 - 10.1016/j.reuma.2020.08.003
Reumatologia Clinica, Vol. 18 Núm. 1 (enero 2022) , p. 33-41  
Detailed record - Creative Commons
2.
8 p, 447.7 KB Clinical, Patient-Reported, and Ultrasound Outcomes from an Open-Label, 12-week Observational : Study of Certolizumab Pegol in Spanish Patients with Rheumatoid Arthritis with or without Prior Anti-TNF Exposure / Blanco-García, F.J (INIBIC-Complejo Hospitalario Universitario A Coruña) ; Rubio-Romero, E. (Hospital Universitario Virgen del Rocío (Sevilla, Andalusia)) ; Sanmartí, Raimon (Hospital Clínic i Provincial de Barcelona) ; Díaz Torne, César (Institut d'Investigació Biomèdica Sant Pau) ; Talavera, P. (UCB Pharma) ; Dunkel, J. (UCB Pharma) ; Naredo, E. (Hospital Fundación Jiménez Díaz) ; Universitat Autònoma de Barcelona
To assess the effectiveness and safety of certolizumab pegol (CZP) in Spanish patients with RA. SONAR (NCT01526434), a 12-week, open-label, prospective, observational, multicenter study. Patients with active RA for ≥3 months, according to ACR criteria, were treated with CZP (400 mg at Weeks 0, 2 and 4, then 200 mg every 2 weeks). [...]
2020 - 10.1016/j.reuma.2018.07.009
Reumatologia Clinica, Vol. 16 Núm. 5 (septiembre 2020) , p. 345-352  
Detailed record - Creative Commons

Interested in being notified about new results for this query?
Set up a personal email alert or subscribe to the RSS feed.
UAB Digital Repository of Documents :: Search :: Submit :: Personalize :: Help
Powered by Invenio v1.1.6
Maintained by ddd.bib@uab.cat  :: Metadata license:
Working with